Publication | Closed Access

Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker

Animal PhysiologyCardiovascular DiseaseMedicinePhysiologyCholesterol-fed RabbitsVascular BiologyPharmacotherapyCardiovascular PhysiologyCardiovascular FunctionPublic HealthPharmacologyAtherosclerosis